Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Thamizhselvi Ganapathy"'
Publikováno v:
Cancer Immunology, Immunotherapy. 72:277-286
Engineered immune cell therapy to treat malignancies refractory to conventional therapies is modernizing oncology. Although αβ T cells are time-tested chassis for CAR, potential graft versus host disease (GvHD) apart from cytokine toxicity and anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c61d3162274016284dc4e99e55f049
https://doi.org/10.1007/s00262-022-03260-y
https://doi.org/10.1007/s00262-022-03260-y
